During this segment, Peter Salgo, MD, defines clinical inertia and explains how it can result in unnecessary, damaging hyperglycemia events that can persist for years in some patients. Additionally, he notes that clinical inertia contributes to costly health complications, higher rates of hospitalizations, and an overall increased use of healthcare resources.

For this reason, Dr Salgo and the panelists explore how healthcare organizations have implemented programs to incentivize healthy behaviors in diabetes patients.

Kari Uusinarkaus, MD, FAAFP, FNLA, discusses how his group has implemented a disease management program that connects an RN “Nurse Navigator” to a patient during hospital discharge. Dr Uusinarkaus explains the importance of this initiative, and highlights another program, called Silver Sneakers, that provides gym access to patients older than 60 years.

However, the panelists recognize that not all initiatives have been successful. For example, despite reducing or limiting the copayments for type 2 diabetes mellitus and obesity drugs, according to Jeffrey D. Dunn, PharmD, MBA, no reliable source of data has revealed changes in patient behavior or improvements in overall outcomes that have come as a result of this reduced cost burden.

Episode 13 - Recognizing and Resolving Clinical Inertia

Peter Salgo, MD; Jeffrey D. Dunn, PharmD, MBA; and Kari Uusinarkaus, MD, FAAFP, FNLA, briefly define clinical inertia, discuss how it continues to remain a costly problem in diabetes care, and share insights about programs that their organizations have implemented to incentivize healthy behaviors and promote the prevention of, or reduction in, serious complications.
Published Online: June 27, 2014
View More From This Discussion
Episode 1 Episode 1 - Prevalence of Diabetes and Obesity in the United States
Episode 2 Episode 2 - Lifestyle Modification Programs-Do They Work?
Episode 3 Episode 3 - Barriers in the Treatment of Obesity
Episode 4 Episode 4 - Role of Pharmacotherapy in the Treatment of Obesity
Episode 5 Episode 5 - Recognizing and Addressing Factors Related to Nonadherence
Episode 6 Episode 6 - Pharmacotherapy Versus Bariatric Surgery
Episode 7 Episode 7 - Barriers When Managing Diabetes
Episode 8 Episode 8 - Changing the T2DM Treatment Paradigm
Episode 9 Episode 9 - Sodium Glucose Cotransporter 2 Inhibitors and Type 2 Diabetes Mellitus
Episode 10 Episode 10 - Additional Sodium Glucose Cotransporter 2 Inhibitors in the Pipeline
Episode 11 Episode 11 - Optimizing Outcomes in Type 2 Diabetes Mellitus
Episode 12 Episode 12 - Support for Patients With Diabetes
Episode 13 Episode 13 - Recognizing and Resolving Clinical Inertia
Episode 14 Episode 14 - Value-Based Care-Can It Work?
Episode 15 Episode 15 - Approaches to Managing the Diabetes Epidemic
Episode 16 Episode 16 - Closing Remarks